Serum Institute of India Sues Covid-19 Vaccine Trial Participant

December 4, 2020

The world’s largest vaccine maker, the Serum Institute of India, has filed a lawsuit in India seeking $13.5 million in damages from a 40-year-old man who alleged he suffered a serious adverse event after being vaccinated in a clinical trial of the AstraZeneca COVID-19 vaccine.

The institute, which is manufacturing the AstraZeneca vaccine and has been conducting trials for it in India, contends that the man’s illness wasn’t caused by the trial and that he is “falsely laying blame” for his medical problems.

The man is reportedly seeking an estimated $676,000 in compensation from the Serum Institute and has requested that further testing in the 1,600-participant trial be stopped.

View today's stories